Annals ofRheumatoid Arthritis

Volume: 4 - Number: 38 - September 15, 2006

Outstanding

A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica

Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis

Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study

Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor ß1 (TGFB1) gene polymorphisms

Clinic

A survey of British rheumatologists’ DMARD preferences for rheumatoid arthritis

Expression of somatostatin receptors in inflammatory lesions and diagnostic value of somatostatin receptor scintigraphy in patients with ANCA-associated small vessel vasculitis

Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings

The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries

Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients

Concise Report

Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis

Extended reports

A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica

A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population

Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF and IL18 but not CXCL13

Expression of resistance markers to methotrexate predicts clinical improvement in patients with rheumatoid arthritis

Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy

Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis

Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis

Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study

Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor ß1 (TGFB1) gene polymorphisms

Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis

Matters arising

HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis • Authors’ reply

NSAIDs, including coxibs, probably do more harm than good, and paracetamol is ineffective for hip OA • Authors’ reply

Meeting reports

Summary of report of the 3rd Workshop of European Biologics Registries

Reviews

Antibiotic treatment of Lyme borreliosis: what is the evidence?